Waters Total Long-Term Assets 2010-2025 | WAT
Waters total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
- Waters total long-term assets for the quarter ending March 31, 2025 were $2.885B, a 0.37% increase year-over-year.
- Waters total long-term assets for 2024 were $2.885B, a 0.37% increase from 2023.
- Waters total long-term assets for 2023 were $2.874B, a 89.38% increase from 2022.
- Waters total long-term assets for 2022 were $1.518B, a 3.52% increase from 2021.
| Waters Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $2,885 |
| 2023 | $2,874 |
| 2022 | $1,518 |
| 2021 | $1,466 |
| 2020 | $1,439 |
| 2019 | $1,245 |
| 2018 | $1,064 |
| 2017 | $1,054 |
| 2016 | $1,027 |
| 2015 | $1,055 |
| 2014 | $1,058 |
| 2013 | $1,026 |
| 2012 | $910 |
| 2011 | $781 |
| 2010 | $741 |
| 2009 | $736 |
| Waters Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2,885 |
| 2024-09-30 | $2,864 |
| 2024-06-30 | $2,845 |
| 2024-03-31 | $2,866 |
| 2023-12-31 | $2,874 |
| 2023-09-30 | $2,863 |
| 2023-06-30 | $2,867 |
| 2023-03-31 | $1,533 |
| 2022-12-31 | $1,518 |
| 2022-09-30 | $1,494 |
| 2022-06-30 | $1,476 |
| 2022-03-31 | $1,456 |
| 2021-12-31 | $1,466 |
| 2021-09-30 | $1,458 |
| 2021-06-30 | $1,465 |
| 2021-03-31 | $1,444 |
| 2020-12-31 | $1,439 |
| 2020-09-30 | $1,388 |
| 2020-06-30 | $1,379 |
| 2020-03-31 | $1,339 |
| 2019-12-31 | $1,245 |
| 2019-09-30 | $1,217 |
| 2019-06-30 | $1,203 |
| 2019-03-31 | $1,172 |
| 2018-12-31 | $1,064 |
| 2018-09-30 | $1,072 |
| 2018-06-30 | $1,034 |
| 2018-03-31 | $1,051 |
| 2017-12-31 | $1,054 |
| 2017-09-30 | $1,084 |
| 2017-06-30 | $1,050 |
| 2017-03-31 | $1,032 |
| 2016-12-31 | $1,027 |
| 2016-09-30 | $1,042 |
| 2016-06-30 | $1,042 |
| 2016-03-31 | $1,058 |
| 2015-12-31 | $1,055 |
| 2015-09-30 | $1,027 |
| 2015-06-30 | $1,022 |
| 2015-03-31 | $997 |
| 2014-12-31 | $1,058 |
| 2014-09-30 | $1,052 |
| 2014-06-30 | $1,047 |
| 2014-03-31 | $1,042 |
| 2013-12-31 | $1,026 |
| 2013-09-30 | $996 |
| 2013-06-30 | $941 |
| 2013-03-31 | $920 |
| 2012-12-31 | $910 |
| 2012-09-30 | $860 |
| 2012-06-30 | $818 |
| 2012-03-31 | $816 |
| 2011-12-31 | $781 |
| 2011-09-30 | $776 |
| 2011-06-30 | $772 |
| 2011-03-31 | $764 |
| 2010-12-31 | $741 |
| 2010-09-30 | $767 |
| 2010-06-30 | $725 |
| 2010-03-31 | $732 |
| 2009-12-31 | $736 |
| 2009-09-30 | $764 |
| 2009-06-30 | $744 |
| 2009-03-31 | $712 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $20.170B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.127B | 83.28 |
| Thermo Fisher Scientific (TMO) | United States | $153.648B | 18.58 |
| Alcon (ALC) | Switzerland | $47.347B | 31.47 |
| Edwards Lifesciences (EW) | United States | $44.043B | 28.82 |
| IDEXX Laboratories (IDXX) | United States | $38.097B | 43.78 |
| DexCom (DXCM) | United States | $31.969B | 49.41 |
| IQVIA Holdings (IQV) | United States | $25.777B | 14.17 |
| Mettler-Toledo (MTD) | United States | $22.100B | 26.28 |
| STERIS (STE) | Ireland | $21.856B | 24.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.308B | 0.00 |
| Hologic (HOLX) | United States | $11.835B | 12.86 |
| Sysmex ADR (SSMXY) | Japan | $11.715B | 0.00 |
| Penumbra (PEN) | United States | $11.306B | 88.74 |
| Globus Medical (GMED) | United States | $9.687B | 22.43 |
| Masimo (MASI) | United States | $8.725B | 32.29 |
| Teleflex (TFX) | United States | $5.328B | 8.79 |
| Glaukos (GKOS) | United States | $4.983B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.125B | 21.61 |
| TransMedics (TMDX) | United States | $3.159B | 92.46 |
| PROCEPT BioRobotics (PRCT) | United States | $2.945B | 0.00 |
| Veracyte (VCYT) | United States | $2.393B | 43.04 |
| LivaNova (LIVN) | United Kingdom | $1.917B | 11.60 |
| Elekta AB (EKTAY) | Sweden | $1.889B | 16.98 |
| Nihon Kohden (NHNKY) | Japan | $1.867B | 10.21 |
| Alphatec Holdings (ATEC) | United States | $1.779B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.420B | 0.00 |
| Artivion (AORT) | United States | $1.171B | 109.68 |
| Pulse Biosciences (PLSE) | United States | $1.113B | 0.00 |
| OPKO Health (OPK) | United States | $1.015B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.991B | 5.27 |
| AxoGen (AXGN) | United States | $0.747B | 0.00 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| IRadimed (IRMD) | United States | $0.649B | 32.92 |
| Mesa Laboratories (MLAB) | United States | $0.641B | 14.01 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.591B | 9.24 |
| RxSight (RXST) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.492B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| NeuroPace (NPCE) | United States | $0.383B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.350B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 6.74 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| CVRx (CVRX) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.190B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.182B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.60 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |